Key facts
- It has raised $5.0M across 1 recorded rounds; the latest was Early Stage VC ($5.0M) in Mar 2025.
- BridgepointMD has filed 2 Form Ds with the SEC since 2024, most recently Mar 2025 ($2.4M sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for BridgepointMD
Funding rounds
1 roundsAbout BridgepointMD
Developer of a healthcare practice performance and patient engagement platform intended to enhance revenue generation and value-based care readiness for specialist practices and at-risk entities. The company's platform offers modular tools for monthly patient outreach, referral management, care navigation, analytics, revenue cycle optimization, and episode-of-care support, integrating into existing clinical and administrative workflows with minimal operational disruption, enabling healthcare specialists and value-focused provider organizations to grow reimbursed fee-for-service revenue, reduce administrative burden, improve alignment with accountable care objectives, and prepare for risk-sharing and bundled-payment models.
- Sector
- Healthcare
- HQ
- Saint Charles, MO, United States
- Founded
- 2023
- Employees
- 10
- Website
- bridgepointmd.com/
- Ownership
- Privately Held (backing)
BridgepointMD doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BridgepointMD shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BridgepointMD in its N-PORT filings yet. We sweep new filings monthly.